Breast Cancer Histopathological Analysis

Breast Cancer Histopathological Analysis

Introduction of Histopathological Analysis

Breast cancer (BC) is a heterogeneous disease, divided into five clinicopathological subtypes based on four markers: estrogen receptor (ER), progesterone receptor (PR), human epidermal growth factor receptor-2 (HER2 and Ki-67). Different subtypes have different biological behaviors, clinical risk factors, natural history, response to individualized treatment, and prognosis. Histopathology is to cut the diseased tissue into slices about a few microns thick, stain them with different methods and then use a microscope to observe the subtle lesions, thereby improving the resolution of naked eye observation thousands of times and deepening the understanding of diseases and lesions. It is one of the most commonly used means to observe and study diseases.

H and E stained digital histology image sample of lobular carcinoma.Fig. 1. H&E stained digital histology image sample of lobular carcinoma. (Peregrina-Barreto H, et al., 2022)

Our Services

Histopathology is the clinical application of histological methods to examine BC cells and tissues for diagnostic or prognostic analysis of various conditions including cancer and multi-organ disease. Services we can provide include:

Histopathology Platform Technology Services
Paraffin sections Frozen sections Tissue microarray HE staining
Oil red dyeing Safranin O staining Masson staining ATPase staining
Giemsa stain VanGieson beam color Spandex dyeing Mesh fiber dyeing
Periodic acid-Schiff Crystal violet staining Congo red staining Alcian blue staining
Sudan dyeing Warthin-starry dyeing Toluidine blue staining TTC staining

Breast Cancer Histopathological Analysis

Diagnostic cytology, histology, and immunohistochemistry rely primarily on analyzing samples by binding dyes, stains, or immunoprobes to key cellular and/or histochemical structures to reveal cellular architecture or pathological conditions. Therefore, the stability and permeability of tissue structure are critical to the consistency and reliability of staining.

Alfa Cytology considers the type and time of tissue fixation, thickness, temperature and target accessibility to ensure the staining effect. Our use of proven analytical methods to preserve and process samples also helps improve tissue analysis using staining, immunoprobe labeling or molecular techniques.

Advantages of Our Services

  • Extensive experience in histopathology research
  • Professional and high-quality team
  • Strict quality control and high efficiency
  • A good after-sales service

Alfa Cytology is a world-leading preclinical CRO company dedicated to assisting scientists around the world in BC research. We can provide you with BC histopathological analysis services and help in the treatment and diagnosis of BC. If you have any questions about BC research, please contact us and our experts will get back to you as soon as possible.

Reference

  1. Peregrina-Barreto H, et al. Characterization of Nuclear Pleomorphism and Tubules in Histopathological Images of Breast Cancer. Sensors (Basel). 2022 Jul 28;22(15):5649.
All our services and products are exclusively intended for preclinical research purposes. They are not intended for diagnostic, therapeutic, or patient management applications.